View in EDS HTML Full Text PDF Full Text

LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trial.

Saved in:
Bibliographic Details
Title: LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trial.
Authors: Loesche, Christian1 (AUTHOR), Picard, Damien1 (AUTHOR), Van Hoorick, Benjamin2 (AUTHOR), Schuhmann, Imelda3 (AUTHOR), Jäger, Petra4 (AUTHOR), Klein, Kai5 (AUTHOR), Schuhler, Carole6 (AUTHOR), Thoma, Gebhard7 (AUTHOR), Markert, Christian7 (AUTHOR), Poller, Birk5 (AUTHOR), Zamurovic, Natasa8 (AUTHOR), Weiss, H. Markus5 (AUTHOR), Otto, Heike4 (AUTHOR), Fink, Martin6 (AUTHOR), Röhn, Till A.4 (AUTHOR) till.roehn@novartis.com
Source: CTS: Clinical & Translational Science. Feb2024, Vol. 17 Issue 2, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17528054
DOI:10.1111/cts.13724